Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

First Rx for HIT type II approved in U.S.

March 10, 1998

U.S. patent covers use of MH-1 to deliver thrombolytics

March 5, 1998

3-D reveals new trypsin-like serine protease inhibitors

March 4, 1998

Acetaminophen increases risk of hemorrhage in combination with warfarin

March 4, 1998

Anticoagulants under development at Astra

March 3, 1998

Saruplase found equivalent to streptokinase in COMPASS trial

March 3, 1998

Corvas prepares new orally active antithrombotic agents

March 2, 1998

Orally active thrombin inhibitors prepared at C&C

Feb. 27, 1998

Cor Therapeutics receives milestone for Integrilin MAA review

Feb. 23, 1998

FDA accepts The Medicines Company's NDA for Hirulog

Feb. 20, 1998

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...